Glimepiride 2mg + Metformin 500mg SR is a combination oral antidiabetic medication used to manage type 2 diabetes mellitus in adults. Glimepiride, a sulfonylurea, works by stimulating insulin secretion from the pancreas, while Metformin (sustained release) reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues. The SR (Sustained Release) formulation ensures gradual release of Metformin, enhancing glycemic control, reducing gastrointestinal side effects, and improving patient compliance. This combination is ideal for patients whose blood sugar is not adequately controlled with diet, exercise, or monotherapy.
